5 Stocks Insiders are Buying Now

4. 89bio Inc (NASDAQ:ETNB)

Number of Hedge Fund Investors: 30

Clinical stage biopharma company 89bio Inc (NASDAQ:ETNB) saw heavy insider buying activity recently as RA Capital Management, which has a director status at 89bio Inc’s (NASDAQ:ETNB) board, loaded up on 1.35 million shares of 89bio Inc (NASDAQ:ETNB) on March 4 at $15.35 per share. Since then through March 10 the stock has lost about 6.1%.